Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients

Transplantation Proceedings

Volumn 37, Issue 4, 2005, Pages 1874-1876

  Pohanka, E ^a   Margreiter, R ^b   Sparacino, V ^c   Sperschneider, H ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c ARNAS Civico Benfratelli G di Cristina and M Ascoli   (Italy)

^d KfH Nierenzentrum Jena   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; GINGIVA HYPERPLASIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECIPIENT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL, LDL; COHORT STUDIES; CYCLOSPORINE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 20344406828     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.03.135     Document Type: Conference Paper

References (6)

1. P.A. Andrews Renal transplantation BMJ 324 2002 530
2. M.A. Artz, J.M.M. Boots, G. Ligtenberg Randomized conversion from cyclosporine to tacrolimus in renal transplant patients improved lipid profile and unchanged plasma homocysteine levels Transplant Proc 34 2002 1793
3. M.J. Bia Nonimmunologic causes of late renal graft loss Kidney Int 47 1995 1470
4. P.C. Brazy, J.D. Pirsch, F.O. Belzer Factors affecting renal allograft function in long-term recipients Am J Kidney Dis 19 1992 558
5. B. Kasiske, F.G. Cosio, J. Beto National Kidney Foundation Clinical practice guidelines for managing dyslipidemias in kidney transplant patients a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative Am J Transplant 4 Suppl 7 2004 13
6. R. Margreiter, E. Pohanka, V. Sparacino Large European study of the switch to tacrolimus for cyclosporine-related side effects Am J Transplant 2 Suppl 3 2002 405